Molecular classification of endometrial cancer: entering an era of precision medicine

por Goulder, Alison, Gaillard, Stéphanie L.
Publicado 2022

The role of immune checkpoint inhibition in the treatment of ovarian cancer

por Gaillard, Stéphanie L., Secord, Angeles A., Monk, Bradley
Publicado 2016

Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy

por Shen, Yao-An, Jung, Jin, Shimberg, Geoffrey D., Hsu, Fang-Chi, Rahmanto, Yohan Suryo, Gaillard, Stephanie L., Hong, Jiaxin, Bosch, Jürgen, Shih, Ie-Ming, Chuang, Chi-Mu, Wang, Tian-Li
Publicado 2021

Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer

por Aquino-Acevedo, Alexandra N., Knochenhauer, Hope, Castillo-Ocampo, Yesenia, Ortiz-León, Melanie, Rivera-López, Yadiel A., Morales-López, Camily, Cruz-Robles, Melanie E., Hernández-Cordero, Elvin R., Russell, Shonagh, Whitaker, Regina, Bonilla-Claudio, Margarita, Chen, Dung-Tsa, Dutil, Julie, Gaillard, Stephanie L., Yi, John S., Previs, Rebecca A., Armaiz-Pena, Guillermo N.
Publicado 2022

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

por Lheureux, Stephanie, Matei, Daniela E, Konstantinopoulos, Panagiotis A, Wang, Ben X, Gadalla, Ramy, Block, Matthew S, Jewell, Andrea, Gaillard, Stephanie L, McHale, Michael, McCourt, Carolyn, Temkin, Sarah, Girda, Eugenia, Backes, Floor J, Werner, Theresa L, Duska, Linda, Kehoe, Siobhan, Colombo, Ilaria, Wang, Lisa, Li, Xuan, Wildman, Rachel, Soleimani, Shirin, Lien, Scott, Wright, John, Pugh, Trevor, Ohashi, Pamela S, Brooks, David G, Fleming, Gini F
Publicado 2022